Your browser doesn't support javascript.
loading
Impact of Atrial Fibrillation on Outcomes in Very Severe Aortic Valve Stenosis.
Ibrahim, Hossam; Thaden, Jeremy J; Fabre, Katarina L; Scott, Christopher G; Greason, Kevin L; Pislaru, Sorin V; Nkomo, Vuyisile T.
Afiliación
  • Ibrahim H; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
  • Thaden JJ; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
  • Fabre KL; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
  • Scott CG; Department of Biostatistics, Mayo Clinic, Rochester, Minnesota.
  • Greason KL; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.
  • Pislaru SV; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
  • Nkomo VT; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: nkomo.vuyisile@mayo.edu.
Am J Cardiol ; 189: 64-69, 2023 02 15.
Article en En | MEDLINE | ID: mdl-36508765
ABSTRACT
The prevalence and impact of atrial fibrillation (AF) versus sinus rhythm (SR) on outcomes in very severe aortic stenosis (vsAS) of the native valve is unknown. The aim of the study was to determine the prognostic significance of AF in vsAS. A total of 563 patients with vsAS (transaortic valve peak velocity ≥5 m/s) and left ventricular ejection fraction ≥50% were identified retrospectively. Patients were divided by rhythm at the time of index transthoracic echocardiogram (AF n = 50 [9%] vs SR n = 513 [91%]). Patients with AF were older (83.1 ± 7.5 vs 72.5 ± 12.2 y, p <0.001) and had no difference in gender distribution (p = 0.49) but had a higher Charlson co-morbidity index (2 [1,3] vs 1 [0,2], p = 0.01). There was no difference in transaortic peak velocity (5.3 ± 0.3 m/s vs 5.4 ± 0.4 m/s, p = 0.13) and left ventricular ejection fraction was comparable (63 ± 7 vs 66 ± 7%, p = 0.01). Age-, gender-, Charlson co-morbidity index-, and time-dependent aortic valve replacement (AVR)-adjusted overall mortality at 5 years was significantly higher in patients with AF than patients with SR (hazard ratio [HR] 1.88 [1.23 to 2.85], p = 0.003). AVR was associated with improved survival (HR = 0.30 [0.22 to 0.42], p <0.001), with no statistically significant interaction of AVR and rhythm (p = 0.36). Outcomes were also compared in the 2 SR1 AF propensity-matched analyses (100 SR 50 AF), with matching done according to age, gender, clinical co-morbidities, and year of echocardiogram. In the propensity-matched analysis, age-, gender-, and time-dependent AVR-adjusted all-cause mortality was higher in AF (HR 2.32 [1.41 to 3.82], p <0.001). In conclusion, AF was not uncommon in vsAS and identified a subset of patients at a much higher risk of mortality without AVR.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Estenosis de la Válvula Aórtica / Fibrilación Atrial / Implantación de Prótesis de Válvulas Cardíacas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Cardiol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Estenosis de la Válvula Aórtica / Fibrilación Atrial / Implantación de Prótesis de Válvulas Cardíacas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Cardiol Año: 2023 Tipo del documento: Article